drugset / Trial / NCT01275144

A Study of the Effect of LY2216684 on Lorazepam

NCT01275144

Phase 1 Completed 28 enrolled Eli Lilly and Company
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine how much lorazepam gets into the blood and how long it takes the body to get rid of it when given together with LY2216684. Information about any side effects that may occur will also be collected.

Timeline

Start
2010-12
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Lorazepam Small molecule 1 mg Oral
Subject edivoxetine Small molecule 18 mg Oral